S. mutans produces tryglysin to inhibit the growth of competing species, including other streptococci that could cause opportunistic infection.
The manipulation of microbiota could improve the outcomes of infections in the respiratory tract cause by opportunistic pathogens.
Gut microbes contribute to symptoms associated with neurological conditions. New microbe-inspired therapies could be develop to treat such conditions.
Some gut microbial metabolites boost the efficacy of antitumor drugs by regulating the body’s immune response and could be used as a part of cancer therapy.
Watch our interview with Bernart Olle, CEO of Vedanta Biosciences.
Executive Director George Paraskevakos presents the role of the International Probiotics Association (IPA) at this year’s Probiotics, Prebiotics & New Foods conference, to be held in September in Rome.
Microbial transplants could be used as a non-invasive and safe strategy to manipulate the gut microbiota, which has been linked to HIV infection.
Common gut fungi called Debaryomyces hansenii can influence the severity of Crohn’s disease and other inflammatory bowel diseases.
Microbial and fungal communities interactions shape the gut microbiota in preterm babies. The findings could help to develop microbiota interventions.
The alterations in gut microbial composition could play a role in the gastrointestinal complications associated with Parkinson’s disease.
